Omicron BQ variants resistant to antibody treatments are quickly becoming dominant in U.S.
November 11, 2022 at 15:11 PM EST
Omicron subvariants BQ.1 and BQ.1.1 now make up 44% of new Covid cases, compared with 32% last week, according to CDC data.
